Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas

Recurrence of meningiomas is unpredictable by current invasive methods based on surgically removed specimens. Identification of patients likely to recur using noninvasive approaches could inform treatment strategy, whether intervention or monitoring. In this study, we analyze the DNA methylation lev...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 14; no. 1; pp. 5669 - 19
Main Authors Herrgott, Grayson A, Snyder, James M, She, Ruicong, Malta, Tathiane M, Sabedot, Thais S, Lee, Ian Y, Pawloski, Jacob, Podolsky-Gondim, Guilherme G, Asmaro, Karam P, Zhang, Jiaqi, Cannella, Cara E, Nelson, Kevin, Thomas, Bartow, deCarvalho, Ana C, Hasselbach, Laura A, Tundo, Kelly M, Newaz, Rehnuma, Transou, Andrea, Morosini, Natalia, Francisco, Victor, Poisson, Laila M, Chitale, Dhananjay, Mukherjee, Abir, Mosella, Maritza S, Robin, Adam M, Walbert, Tobias, Rosenblum, Mark, Mikkelsen, Tom, Kalkanis, Steven, Tirapelli, Daniela P C, Weisenberger, Daniel J, Carlotti, Jr, Carlos G, Rock, Jack, Castro, Ana Valeria, Noushmehr, Houtan
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 13.09.2023
Nature Publishing Group UK
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Recurrence of meningiomas is unpredictable by current invasive methods based on surgically removed specimens. Identification of patients likely to recur using noninvasive approaches could inform treatment strategy, whether intervention or monitoring. In this study, we analyze the DNA methylation levels in blood (serum and plasma) and tissue samples from 155 meningioma patients, compared to other central nervous system tumor and non-tumor entities. We discover DNA methylation markers unique to meningiomas and use artificial intelligence to create accurate and universal models for identifying and predicting meningioma recurrence, using either blood or tissue samples. Here we show that liquid biopsy is a potential noninvasive and reliable tool for diagnosing and predicting outcomes in meningioma patients. This approach can improve personalized management strategies for these patients.
AbstractList Recurrence of meningiomas is unpredictable by current invasive methods based on surgically removed specimens. Identification of patients likely to recur using noninvasive approaches could inform treatment strategy, whether intervention or monitoring. In this study, we analyze the DNA methylation levels in blood (serum and plasma) and tissue samples from 155 meningioma patients, compared to other central nervous system tumor and non-tumor entities. We discover DNA methylation markers unique to meningiomas and use artificial intelligence to create accurate and universal models for identifying and predicting meningioma recurrence, using either blood or tissue samples. Here we show that liquid biopsy is a potential noninvasive and reliable tool for diagnosing and predicting outcomes in meningioma patients. This approach can improve personalized management strategies for these patients.
Recurrence of meningiomas is unpredictable by current invasive methods based on surgically removed specimens. Identification of patients likely to recur using noninvasive approaches could inform treatment strategy, whether intervention or monitoring. In this study, we analyze the DNA methylation levels in blood (serum and plasma) and tissue samples from 155 meningioma patients, compared to other central nervous system tumor and non-tumor entities. We discover DNA methylation markers unique to meningiomas and use artificial intelligence to create accurate and universal models for identifying and predicting meningioma recurrence, using either blood or tissue samples. Here we show that liquid biopsy is a potential noninvasive and reliable tool for diagnosing and predicting outcomes in meningioma patients. This approach can improve personalized management strategies for these patients.Recurrence of meningiomas is unpredictable by current methods based on surgically removed specimens, and identification of patients likely to recur could inform treatment strategy. Here, the authors analysed DNA methylation in liquid biopsy specimens from meningioma patients to help classify recurrence risk noninvasively even before surgery.
Abstract Recurrence of meningiomas is unpredictable by current invasive methods based on surgically removed specimens. Identification of patients likely to recur using noninvasive approaches could inform treatment strategy, whether intervention or monitoring. In this study, we analyze the DNA methylation levels in blood (serum and plasma) and tissue samples from 155 meningioma patients, compared to other central nervous system tumor and non-tumor entities. We discover DNA methylation markers unique to meningiomas and use artificial intelligence to create accurate and universal models for identifying and predicting meningioma recurrence, using either blood or tissue samples. Here we show that liquid biopsy is a potential noninvasive and reliable tool for diagnosing and predicting outcomes in meningioma patients. This approach can improve personalized management strategies for these patients.
Recurrence of meningiomas is unpredictable by current invasive methods based on surgically removed specimens. Identification of patients likely to recur using noninvasive approaches could inform treatment strategy, whether intervention or monitoring. In this study, we analyze the DNA methylation levels in blood (serum and plasma) and tissue samples from 155 meningioma patients, compared to other central nervous system tumor and non-tumor entities. We discover DNA methylation markers unique to meningiomas and use artificial intelligence to create accurate and universal models for identifying and predicting meningioma recurrence, using either blood or tissue samples. Here we show that liquid biopsy is a potential noninvasive and reliable tool for diagnosing and predicting outcomes in meningioma patients. This approach can improve personalized management strategies for these patients. Recurrence of meningiomas is unpredictable by current methods based on surgically removed specimens, and identification of patients likely to recur could inform treatment strategy. Here, the authors analysed DNA methylation in liquid biopsy specimens from meningioma patients to help classify recurrence risk noninvasively even before surgery.
Recurrence of meningiomas is unpredictable by current invasive methods based on surgically removed specimens. Identification of patients likely to recur using noninvasive approaches could inform treatment strategy, whether intervention or monitoring. In this study, we analyze the DNA methylation levels in blood (serum and plasma) and tissue samples from 155 meningioma patients, compared to other central nervous system tumor and non-tumor entities. We discover DNA methylation markers unique to meningiomas and use artificial intelligence to create accurate and universal models for identifying and predicting meningioma recurrence, using either blood or tissue samples. Here we show that liquid biopsy is a potential noninvasive and reliable tool for diagnosing and predicting outcomes in meningioma patients. This approach can improve personalized management strategies for these patients.Recurrence of meningiomas is unpredictable by current invasive methods based on surgically removed specimens. Identification of patients likely to recur using noninvasive approaches could inform treatment strategy, whether intervention or monitoring. In this study, we analyze the DNA methylation levels in blood (serum and plasma) and tissue samples from 155 meningioma patients, compared to other central nervous system tumor and non-tumor entities. We discover DNA methylation markers unique to meningiomas and use artificial intelligence to create accurate and universal models for identifying and predicting meningioma recurrence, using either blood or tissue samples. Here we show that liquid biopsy is a potential noninvasive and reliable tool for diagnosing and predicting outcomes in meningioma patients. This approach can improve personalized management strategies for these patients.
Abstract Recurrence of meningiomas is unpredictable by current invasive methods based on surgically removed specimens. Identification of patients likely to recur using noninvasive approaches could inform treatment strategy, whether intervention or monitoring. In this study, we analyze the DNA methylation levels in blood (serum and plasma) and tissue samples from 155 meningioma patients, compared to other central nervous system tumor and non-tumor entities. We discover DNA methylation markers unique to meningiomas and use artificial intelligence to create accurate and universal models for identifying and predicting meningioma recurrence, using either blood or tissue samples. Here we show that liquid biopsy is a potential noninvasive and reliable tool for diagnosing and predicting outcomes in meningioma patients. This approach can improve personalized management strategies for these patients.
ArticleNumber 5669
Author Thomas, Bartow
Rock, Jack
Tundo, Kelly M
Poisson, Laila M
Lee, Ian Y
Kalkanis, Steven
Hasselbach, Laura A
Podolsky-Gondim, Guilherme G
Carlotti, Jr, Carlos G
Malta, Tathiane M
Herrgott, Grayson A
Snyder, James M
Asmaro, Karam P
Zhang, Jiaqi
Mosella, Maritza S
Castro, Ana Valeria
Pawloski, Jacob
Cannella, Cara E
Transou, Andrea
Mukherjee, Abir
Newaz, Rehnuma
Sabedot, Thais S
deCarvalho, Ana C
Tirapelli, Daniela P C
Noushmehr, Houtan
Rosenblum, Mark
Chitale, Dhananjay
Mikkelsen, Tom
Nelson, Kevin
She, Ruicong
Morosini, Natalia
Francisco, Victor
Weisenberger, Daniel J
Robin, Adam M
Walbert, Tobias
Author_xml – sequence: 1
  givenname: Grayson A
  surname: Herrgott
  fullname: Herrgott, Grayson A
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 2
  givenname: James M
  surname: Snyder
  fullname: Snyder, James M
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 3
  givenname: Ruicong
  surname: She
  fullname: She, Ruicong
  organization: Department of Public Health, Biostatistics, Henry Ford Health, Detroit, MI, USA
– sequence: 4
  givenname: Tathiane M
  surname: Malta
  fullname: Malta, Tathiane M
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 5
  givenname: Thais S
  surname: Sabedot
  fullname: Sabedot, Thais S
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 6
  givenname: Ian Y
  surname: Lee
  fullname: Lee, Ian Y
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 7
  givenname: Jacob
  surname: Pawloski
  fullname: Pawloski, Jacob
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 8
  givenname: Guilherme G
  orcidid: 0000-0002-9608-2607
  surname: Podolsky-Gondim
  fullname: Podolsky-Gondim, Guilherme G
  organization: Department of Neurosurgery, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil
– sequence: 9
  givenname: Karam P
  surname: Asmaro
  fullname: Asmaro, Karam P
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 10
  givenname: Jiaqi
  surname: Zhang
  fullname: Zhang, Jiaqi
  organization: Department of Public Health, Biostatistics, Henry Ford Health, Detroit, MI, USA
– sequence: 11
  givenname: Cara E
  surname: Cannella
  fullname: Cannella, Cara E
  organization: Department of Public Health, Biostatistics, Henry Ford Health, Detroit, MI, USA
– sequence: 12
  givenname: Kevin
  surname: Nelson
  fullname: Nelson, Kevin
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 13
  givenname: Bartow
  surname: Thomas
  fullname: Thomas, Bartow
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 14
  givenname: Ana C
  orcidid: 0000-0003-1183-4548
  surname: deCarvalho
  fullname: deCarvalho, Ana C
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 15
  givenname: Laura A
  surname: Hasselbach
  fullname: Hasselbach, Laura A
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 16
  givenname: Kelly M
  surname: Tundo
  fullname: Tundo, Kelly M
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 17
  givenname: Rehnuma
  surname: Newaz
  fullname: Newaz, Rehnuma
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 18
  givenname: Andrea
  surname: Transou
  fullname: Transou, Andrea
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 19
  givenname: Natalia
  surname: Morosini
  fullname: Morosini, Natalia
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 20
  givenname: Victor
  surname: Francisco
  fullname: Francisco, Victor
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 21
  givenname: Laila M
  orcidid: 0000-0002-3409-6536
  surname: Poisson
  fullname: Poisson, Laila M
  organization: Department of Public Health, Biostatistics, Henry Ford Health, Detroit, MI, USA
– sequence: 22
  givenname: Dhananjay
  orcidid: 0000-0002-4421-6431
  surname: Chitale
  fullname: Chitale, Dhananjay
  organization: Department of Pathology, Henry Ford Health, Detroit, MI, USA
– sequence: 23
  givenname: Abir
  surname: Mukherjee
  fullname: Mukherjee, Abir
  organization: Department of Pathology, Henry Ford Health, Detroit, MI, USA
– sequence: 24
  givenname: Maritza S
  surname: Mosella
  fullname: Mosella, Maritza S
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 25
  givenname: Adam M
  surname: Robin
  fullname: Robin, Adam M
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 26
  givenname: Tobias
  orcidid: 0000-0003-0667-8106
  surname: Walbert
  fullname: Walbert, Tobias
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 27
  givenname: Mark
  surname: Rosenblum
  fullname: Rosenblum, Mark
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 28
  givenname: Tom
  surname: Mikkelsen
  fullname: Mikkelsen, Tom
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 29
  givenname: Steven
  surname: Kalkanis
  fullname: Kalkanis, Steven
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 30
  givenname: Daniela P C
  surname: Tirapelli
  fullname: Tirapelli, Daniela P C
  organization: Department of Neurosurgery, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil
– sequence: 31
  givenname: Daniel J
  orcidid: 0000-0001-8303-2603
  surname: Weisenberger
  fullname: Weisenberger, Daniel J
  organization: Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA
– sequence: 32
  givenname: Carlos G
  surname: Carlotti, Jr
  fullname: Carlotti, Jr, Carlos G
  organization: Department of Neurosurgery, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil
– sequence: 33
  givenname: Jack
  surname: Rock
  fullname: Rock, Jack
  organization: Department of Neurosurgery, Omics Laboratory, Hermelin Brain Tumor Center, Henry Ford Health, Detroit, MI, USA
– sequence: 34
  givenname: Ana Valeria
  orcidid: 0000-0003-1625-0015
  surname: Castro
  fullname: Castro, Ana Valeria
  email: acastro1@hfhs.org, acastro1@hfhs.org
  organization: Department of Physiology, Michigan State University, E. Lansing, MI, USA. acastro1@hfhs.org
– sequence: 35
  givenname: Houtan
  surname: Noushmehr
  fullname: Noushmehr, Houtan
  email: hnoushm1@hfhs.org, hnoushm1@hfhs.org
  organization: Department of Physiology, Michigan State University, E. Lansing, MI, USA. hnoushm1@hfhs.org
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37704607$$D View this record in MEDLINE/PubMed
BookMark eNpdkktv1DAUhSNUREvpH2CBLLFhE_Arsb1CqLwqVWIDa8txrjMeJXZqJ6CpxH_HM9NWLd74Xvu7Rz7WeVmdhBigql4T_J5gJj9kTngrakxZXSrG69tn1RnFnNREUHbyqD6tLnLe4rKYIpLzF9UpEwLzFouz6u9nWMAuPgYUHeq9GULMi7fIhB7NKd63Eyyb3Wj2YN2ZDD3KfghmWRNk5AMa_c3qe9T5OOcdyjNYP0HIyKU4obnMQVgy-uOXTZEKPgw-Tia_qp47M2a4uNvPq19fv_y8_F5f__h2dfnpurZciaWWjQVpG0U5b1kjrHIgS8U4bbkC0beSiMY5sNQBLhh2FguwDQXDuDLAzquro24fzVbPyU8m7XQ0Xh8OYhq0ScXmCLoXmHaKN7x1gmPSdi0TnDnSCwfOtnutj0etee0m6G0xlsz4RPTpTfAbPcTfmmCulMSiKLy7U0jxZoW86MlnC-NoAsQ1aypbLpUq_gr69j90G9cUyl8dKCaVaPYUPVI2xZwTuIfXEKz3adHHtOiSFn1Ii74tQ28e-3gYuc8G-wfd2b-B
CitedBy_id crossref_primary_10_1016_j_neuint_2023_105643
crossref_primary_10_1016_j_heliyon_2024_e25571
crossref_primary_10_1016_j_csbj_2024_01_024
crossref_primary_10_3389_fonc_2024_1395985
crossref_primary_10_3390_ijms25084195
crossref_primary_10_3389_fneur_2023_1321895
Cites_doi 10.1007/s00401-015-1398-z
10.1016/j.jmoldx.2020.05.006
10.1093/clinchem/hvaa103
10.17632/5pzd2rg5ys.2
10.1172/JCI69740
10.1016/j.cell.2015.12.028
10.1093/nar/gky955
10.1186/s13148-019-0779-x
10.1055/s-0039-3399489
10.1038/s41467-021-27864-7
10.1093/database/bax028
10.1038/s41398-019-0376-y
10.1016/S0090-3019(02)00831-5
10.1038/s41467-018-07466-6
10.1007/s002340000419
10.3389/fonc.2020.585313
10.1371/journal.pone.0054114
10.1038/nature26000
10.1016/j.annonc.2021.05.806
10.1016/j.jmoldx.2016.08.007
10.1186/s13148-019-0766-2
10.1016/S1470-2045(17)30155-9
10.1038/s41588-022-01061-8
10.2217/cns-2018-0015
10.1097/MD.0000000000018644
10.3390/cancers13051113
10.3390/genes13112075
10.1093/neuonc/noab023
10.1186/s13045-022-01307-2
10.1038/s41591-020-0932-2
10.1093/neuonc/noy137
10.1038/s41596-019-0202-2
10.18632/oncotarget.24498
10.12688/f1000research.4680.2
10.1093/nar/gkt090
10.1080/00365513.2019.1677938
10.1038/ncomms14433
10.1093/neuonc/noac202
10.3390/life12040586
10.1016/j.wneu.2020.03.060
10.17632/zrc982rvjm.2
10.1038/ng.3651
10.1093/neuonc/noac050
10.1111/bpa.13037
10.1186/s13148-021-01210-6
10.1007/s00401-018-1879-y
10.3389/fonc.2020.592470
10.1016/j.trecan.2019.12.006
10.1093/neuonc/noab150
10.1186/s12864-019-5761-7
10.1007/s00401-017-1678-x
10.1093/neuonc/noab044
10.1145/2939672.2939785
10.1126/sciadv.abm6247
10.1371/journal.pone.0096178
10.1007/s10654-011-9561-x
10.1038/s41586-021-03850-3
10.1093/neuonc/not330
10.1016/j.mce.2018.01.020
10.1093/neuonc/noz160
10.1371/journal.pone.0252480
10.1093/neuonc/noz061
10.1093/neuonc/noab106
10.1093/bioinformatics/btq170
10.1093/neuonc/noy143
10.3390/cancers14194818
10.3390/genes10010032
10.1200/JCO.21.00784
10.1186/s13059-017-1191-5
10.3390/cancers13112664
ContentType Journal Article
Copyright 2023. Springer Nature Limited.
The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Springer Nature Limited 2023
Copyright_xml – notice: 2023. Springer Nature Limited.
– notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Springer Nature Limited 2023
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PIMPY
PQEST
PQQKQ
PQUKI
RC3
SOI
7X8
5PM
DOA
DOI 10.1038/s41467-023-41434-z
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
Advanced Technologies & Aerospace Database‎ (1962 - current)
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Publicly Available Content (ProQuest)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
Genetics Abstracts
Environment Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
Environmental Sciences and Pollution Management
Health Research Premium Collection
Natural Science Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
Technology Collection
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
Publicly Available Content Database


MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-1723
EndPage 19
ExternalDocumentID oai_doaj_org_article_d702b94546f74016b63743f1d7fefc6e
10_1038_s41467_023_41434_z
37704607
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA270365
– fundername: ;
– fundername: ;
  grantid: R01CA270365; R01CA270365
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAADF
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACPRK
ACSMW
ADBBV
ADFRT
ADRAZ
AENEX
AFGXO
AFKRA
AFRAH
AHMBA
AJTQC
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
CCPQU
CGR
CUY
CVF
DIK
EBS
ECM
EE.
EIF
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LGEZI
LK8
LOTEE
M1P
M48
M7P
M~E
NADUK
NAO
NPM
NXXTH
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
ZA5
AAHBH
AAYXX
ACMJI
ALIPV
C6C
CITATION
EBLON
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
P64
PQEST
PQUKI
RC3
SOI
7X8
5PM
ID FETCH-LOGICAL-c497t-85ce8c592446357c9fe8463342649e7d68175ffec2fe05920fc07ec52ea349ae3
IEDL.DBID RPM
ISSN 2041-1723
IngestDate Thu Jul 04 21:08:39 EDT 2024
Tue Sep 17 21:29:35 EDT 2024
Fri Aug 30 19:47:15 EDT 2024
Thu Aug 29 12:41:01 EDT 2024
Fri Aug 23 02:41:55 EDT 2024
Thu May 23 23:28:47 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2023. Springer Nature Limited.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c497t-85ce8c592446357c9fe8463342649e7d68175ffec2fe05920fc07ec52ea349ae3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-3409-6536
0000-0003-1183-4548
0000-0003-0667-8106
0000-0003-1625-0015
0000-0001-8303-2603
0000-0002-4421-6431
0000-0002-9608-2607
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499807/
PMID 37704607
PQID 2864389754
PQPubID 546298
PageCount 19
ParticipantIDs doaj_primary_oai_doaj_org_article_d702b94546f74016b63743f1d7fefc6e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10499807
proquest_miscellaneous_2864899334
proquest_journals_2864389754
crossref_primary_10_1038_s41467_023_41434_z
pubmed_primary_37704607
PublicationCentury 2000
PublicationDate 2023-09-13
PublicationDateYYYYMMDD 2023-09-13
PublicationDate_xml – month: 09
  year: 2023
  text: 2023-09-13
  day: 13
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Nature communications
PublicationTitleAlternate Nat Commun
PublicationYear 2023
Publisher Nature Publishing Group
Nature Publishing Group UK
Nature Portfolio
Publisher_xml – name: Nature Publishing Group
– name: Nature Publishing Group UK
– name: Nature Portfolio
References Z Zador (41434_CR46) 2020; 10
RD Neal (41434_CR66) 2022; 14
F Nassiri (41434_CR11) 2021; 597
PR Braun (41434_CR31) 2019; 9
W Zhou (41434_CR73) 2017; 45
AJ Mitchell (41434_CR82) 2011; 26
D Roy (41434_CR42) 2020; 6
B Luo (41434_CR63) 2022; 20
J-P Fortin (41434_CR71) 2014; 3
KG Ashwath (41434_CR59) 2019; 10
MD Wilkerson (41434_CR74) 2010; 26
F Pittella-Silva (41434_CR52) 2020; 66
V Constâncio (41434_CR53) 2019; 11
D Capper (41434_CR7) 2018; 136
T Ius (41434_CR3) 2021; 13
DE Piccioni (41434_CR27) 2019; 8
C Ling (41434_CR36) 2014; 9
M Widschwendter (41434_CR54) 2017; 9
SY Shen (41434_CR65) 2019; 14
F Liu (41434_CR45) 2021; 13
JC Bayley (41434_CR18) 2022; 8
J Moss (41434_CR41) 2018; 9
A Åsberg (41434_CR83) 2019; 79
F Nassiri (41434_CR28) 2020; 26
L Xu (41434_CR60) 2022; 15
W Gai (41434_CR25) 2019; 10
GA Herrgott (41434_CR29) 2022; 24
41434_CR85
TS Sabedot (41434_CR26) 2021; 23
DJ Weisenberger (41434_CR69) 2014; 124
41434_CR84
RY Huang (41434_CR23) 2019; 21
J Dong (41434_CR43) 2020; 2020
S Fishilevich (41434_CR79) 2017; 2017
KJ Suh (41434_CR61) 2021; 16
M Bendszus (41434_CR20) 2001; 43
MS Mosella (41434_CR13) 2021; 23
Z Zhu (41434_CR47) 2020; 10
41434_CR49
QT Ostrom (41434_CR1) 2022; 24
J Liu (41434_CR64) 2021; 20
F Nassiri (41434_CR10) 2019; 21
T Gerber (41434_CR51) 2020; 22
EA Sloan (41434_CR70) 2022; 32
SLN Maas (41434_CR15) 2021; 39
F Gao (41434_CR33) 2013; 8
S Kang (41434_CR55) 2017; 18
R Rumba (41434_CR62) 2018; 25
S Karimi (41434_CR40) 2019; 11
N Liu (41434_CR44) 2020; 99
A Frankish (41434_CR80) 2019; 47
EA Klein (41434_CR67) 2021; 32
LC Schenkel (41434_CR76) 2022; 13
T Kaley (41434_CR5) 2014; 16
41434_CR38
A Olar (41434_CR17) 2015; 129
P Tagle (41434_CR19) 2002; 58
AS Harmancı (41434_CR34) 2018; 9
J Wang (41434_CR24) 2017; 19
O Morin (41434_CR48) 2019; 1
G Mansell (41434_CR75) 2019; 20
A Chakravarthy (41434_CR39) 2018; 9
LA Salas (41434_CR37) 2022; 13
Y Gao (41434_CR57) 2022; 12
B Meyer (41434_CR77) 2021; 13
TJ Triche (41434_CR72) 2013; 41
A Olar (41434_CR9) 2017; 133
A Olar (41434_CR30) 2018; 9
AI Islim (41434_CR21) 2020; 138
AS Harmancı (41434_CR50) 2017; 8
D Capper (41434_CR32) 2018; 555
F Sahm (41434_CR8) 2017; 18
AI Islim (41434_CR22) 2020; 22
DN Louis (41434_CR14) 2021; 23
D Chicco (41434_CR81) 2021; 14
A-M Barciszewska (41434_CR12) 2020; 20
P Kober (41434_CR35) 2018; 473
A Choudhury (41434_CR16) 2022; 54
H-T Li (41434_CR56) 2022; 13
R Goldbrunner (41434_CR4) 2021; 23
RY Huang (41434_CR2) 2019; 21
Y Kuranari (41434_CR58) 2020; 10
VE Clark (41434_CR68) 2016; 48
Y Liu (41434_CR78) 2019; 19
M Ceccarelli (41434_CR6) 2016; 164
References_xml – volume: 129
  start-page: 585
  year: 2015
  ident: 41434_CR17
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-015-1398-z
  contributor:
    fullname: A Olar
– volume: 22
  start-page: 1070
  year: 2020
  ident: 41434_CR51
  publication-title: J. Mol. Diagn.
  doi: 10.1016/j.jmoldx.2020.05.006
  contributor:
    fullname: T Gerber
– volume: 66
  start-page: 946
  year: 2020
  ident: 41434_CR52
  publication-title: Clin. Chem.
  doi: 10.1093/clinchem/hvaa103
  contributor:
    fullname: F Pittella-Silva
– ident: 41434_CR85
  doi: 10.17632/5pzd2rg5ys.2
– volume: 124
  start-page: 17
  year: 2014
  ident: 41434_CR69
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI69740
  contributor:
    fullname: DJ Weisenberger
– volume: 164
  start-page: 550
  year: 2016
  ident: 41434_CR6
  publication-title: Cell
  doi: 10.1016/j.cell.2015.12.028
  contributor:
    fullname: M Ceccarelli
– volume: 47
  start-page: D766
  year: 2019
  ident: 41434_CR80
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gky955
  contributor:
    fullname: A Frankish
– volume: 11
  year: 2019
  ident: 41434_CR53
  publication-title: Clin. Epigenetics
  doi: 10.1186/s13148-019-0779-x
  contributor:
    fullname: V Constâncio
– volume: 10
  start-page: 648
  year: 2019
  ident: 41434_CR59
  publication-title: J. Neurosci. Rural Pract.
  doi: 10.1055/s-0039-3399489
  contributor:
    fullname: KG Ashwath
– volume: 9
  year: 2018
  ident: 41434_CR34
  publication-title: Nat. Commun.
  contributor:
    fullname: AS Harmancı
– volume: 13
  year: 2022
  ident: 41434_CR37
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-27864-7
  contributor:
    fullname: LA Salas
– volume: 2017
  start-page: bax028
  year: 2017
  ident: 41434_CR79
  publication-title: Database
  doi: 10.1093/database/bax028
  contributor:
    fullname: S Fishilevich
– volume: 1
  start-page: vdz011
  year: 2019
  ident: 41434_CR48
  publication-title: Neurooncol Adv.
  contributor:
    fullname: O Morin
– volume: 9
  year: 2019
  ident: 41434_CR31
  publication-title: Transl. Psychiatry
  doi: 10.1038/s41398-019-0376-y
  contributor:
    fullname: PR Braun
– volume: 58
  start-page: 241
  year: 2002
  ident: 41434_CR19
  publication-title: Surg. Neurol.
  doi: 10.1016/S0090-3019(02)00831-5
  contributor:
    fullname: P Tagle
– volume: 25
  start-page: 185
  year: 2018
  ident: 41434_CR62
  publication-title: Acta Med. Litu.
  contributor:
    fullname: R Rumba
– volume: 9
  year: 2018
  ident: 41434_CR41
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-07466-6
  contributor:
    fullname: J Moss
– volume: 43
  start-page: 285
  year: 2001
  ident: 41434_CR20
  publication-title: Neuroradiology
  doi: 10.1007/s002340000419
  contributor:
    fullname: M Bendszus
– volume: 10
  start-page: 585313
  year: 2020
  ident: 41434_CR47
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2020.585313
  contributor:
    fullname: Z Zhu
– volume: 9
  year: 2018
  ident: 41434_CR39
  publication-title: Nat. Commun.
  contributor:
    fullname: A Chakravarthy
– volume: 20
  year: 2020
  ident: 41434_CR12
  publication-title: BMC Cancer
  contributor:
    fullname: A-M Barciszewska
– volume: 8
  start-page: e54114
  year: 2013
  ident: 41434_CR33
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0054114
  contributor:
    fullname: F Gao
– volume: 555
  start-page: 469
  year: 2018
  ident: 41434_CR32
  publication-title: Nature
  doi: 10.1038/nature26000
  contributor:
    fullname: D Capper
– volume: 32
  start-page: 1167
  year: 2021
  ident: 41434_CR67
  publication-title: Ann. Oncol.
  doi: 10.1016/j.annonc.2021.05.806
  contributor:
    fullname: EA Klein
– volume: 19
  start-page: 24
  year: 2017
  ident: 41434_CR24
  publication-title: J. Mol. Diagn.
  doi: 10.1016/j.jmoldx.2016.08.007
  contributor:
    fullname: J Wang
– volume: 11
  year: 2019
  ident: 41434_CR40
  publication-title: Clin. Epigenetics
  doi: 10.1186/s13148-019-0766-2
  contributor:
    fullname: S Karimi
– volume: 18
  start-page: 682
  year: 2017
  ident: 41434_CR8
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(17)30155-9
  contributor:
    fullname: F Sahm
– volume: 54
  start-page: 649
  year: 2022
  ident: 41434_CR16
  publication-title: Nat. Genet.
  doi: 10.1038/s41588-022-01061-8
  contributor:
    fullname: A Choudhury
– volume: 8
  start-page: CNS34
  year: 2019
  ident: 41434_CR27
  publication-title: CNS Oncol.
  doi: 10.2217/cns-2018-0015
  contributor:
    fullname: DE Piccioni
– volume: 99
  start-page: e18644
  year: 2020
  ident: 41434_CR44
  publication-title: Med. (Baltim.)
  doi: 10.1097/MD.0000000000018644
  contributor:
    fullname: N Liu
– volume: 13
  start-page: 1113
  year: 2021
  ident: 41434_CR45
  publication-title: Cancers
  doi: 10.3390/cancers13051113
  contributor:
    fullname: F Liu
– volume: 20
  year: 2022
  ident: 41434_CR63
  publication-title: BMC Med.
  contributor:
    fullname: B Luo
– volume: 13
  start-page: 2075
  year: 2022
  ident: 41434_CR76
  publication-title: Genes
  doi: 10.3390/genes13112075
  contributor:
    fullname: LC Schenkel
– volume: 23
  start-page: 1494
  year: 2021
  ident: 41434_CR26
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noab023
  contributor:
    fullname: TS Sabedot
– volume: 15
  start-page: 87
  year: 2022
  ident: 41434_CR60
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/s13045-022-01307-2
  contributor:
    fullname: L Xu
– volume: 26
  start-page: 1044
  year: 2020
  ident: 41434_CR28
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-0932-2
  contributor:
    fullname: F Nassiri
– volume: 9
  year: 2017
  ident: 41434_CR54
  publication-title: Genome Med.
  contributor:
    fullname: M Widschwendter
– volume: 21
  start-page: 26
  year: 2019
  ident: 41434_CR23
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noy137
  contributor:
    fullname: RY Huang
– volume: 45
  start-page: e22
  year: 2017
  ident: 41434_CR73
  publication-title: Nucleic Acids Res
  contributor:
    fullname: W Zhou
– volume: 14
  start-page: 2749
  year: 2019
  ident: 41434_CR65
  publication-title: Nat. Protoc.
  doi: 10.1038/s41596-019-0202-2
  contributor:
    fullname: SY Shen
– volume: 9
  start-page: 16087
  year: 2018
  ident: 41434_CR30
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.24498
  contributor:
    fullname: A Olar
– volume: 3
  start-page: 175
  year: 2014
  ident: 41434_CR71
  publication-title: F1000Res.
  doi: 10.12688/f1000research.4680.2
  contributor:
    fullname: J-P Fortin
– volume: 41
  start-page: e90
  year: 2013
  ident: 41434_CR72
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkt090
  contributor:
    fullname: TJ Triche
– volume: 79
  start-page: 560
  year: 2019
  ident: 41434_CR83
  publication-title: Scand. J. Clin. Lab. Invest.
  doi: 10.1080/00365513.2019.1677938
  contributor:
    fullname: A Åsberg
– volume: 8
  year: 2017
  ident: 41434_CR50
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms14433
  contributor:
    fullname: AS Harmancı
– volume: 24
  start-page: v1
  year: 2022
  ident: 41434_CR1
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noac202
  contributor:
    fullname: QT Ostrom
– volume: 13
  year: 2022
  ident: 41434_CR56
  publication-title: Nat. Commun.
  contributor:
    fullname: H-T Li
– volume: 12
  year: 2022
  ident: 41434_CR57
  publication-title: Clin. Transl. Med.
  contributor:
    fullname: Y Gao
– ident: 41434_CR49
  doi: 10.3390/life12040586
– volume: 138
  start-page: e725
  year: 2020
  ident: 41434_CR21
  publication-title: World Neurosurg.
  doi: 10.1016/j.wneu.2020.03.060
  contributor:
    fullname: AI Islim
– ident: 41434_CR84
  doi: 10.17632/zrc982rvjm.2
– volume: 48
  start-page: 1253
  year: 2016
  ident: 41434_CR68
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3651
  contributor:
    fullname: VE Clark
– volume: 24
  start-page: 1126
  year: 2022
  ident: 41434_CR29
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noac050
  contributor:
    fullname: GA Herrgott
– volume: 32
  start-page: e13037
  year: 2022
  ident: 41434_CR70
  publication-title: Brain Pathol.
  doi: 10.1111/bpa.13037
  contributor:
    fullname: EA Sloan
– volume: 13
  year: 2021
  ident: 41434_CR77
  publication-title: Clin. Epigenetics
  doi: 10.1186/s13148-021-01210-6
  contributor:
    fullname: B Meyer
– volume: 136
  start-page: 181
  year: 2018
  ident: 41434_CR7
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-018-1879-y
  contributor:
    fullname: D Capper
– volume: 10
  start-page: 592470
  year: 2020
  ident: 41434_CR58
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2020.592470
  contributor:
    fullname: Y Kuranari
– volume: 6
  start-page: 78
  year: 2020
  ident: 41434_CR42
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2019.12.006
  contributor:
    fullname: D Roy
– volume: 23
  start-page: 1821
  year: 2021
  ident: 41434_CR4
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noab150
  contributor:
    fullname: R Goldbrunner
– volume: 20
  year: 2019
  ident: 41434_CR75
  publication-title: BMC Genomics
  doi: 10.1186/s12864-019-5761-7
  contributor:
    fullname: G Mansell
– volume: 133
  start-page: 431
  year: 2017
  ident: 41434_CR9
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-017-1678-x
  contributor:
    fullname: A Olar
– volume: 23
  start-page: 1292
  year: 2021
  ident: 41434_CR13
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noab044
  contributor:
    fullname: MS Mosella
– ident: 41434_CR38
  doi: 10.1145/2939672.2939785
– volume: 8
  start-page: eabm6247
  year: 2022
  ident: 41434_CR18
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.abm6247
  contributor:
    fullname: JC Bayley
– volume: 9
  start-page: e96178
  year: 2014
  ident: 41434_CR36
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0096178
  contributor:
    fullname: C Ling
– volume: 26
  start-page: 251
  year: 2011
  ident: 41434_CR82
  publication-title: Eur. J. Epidemiol.
  doi: 10.1007/s10654-011-9561-x
  contributor:
    fullname: AJ Mitchell
– volume: 597
  start-page: 119
  year: 2021
  ident: 41434_CR11
  publication-title: Nature
  doi: 10.1038/s41586-021-03850-3
  contributor:
    fullname: F Nassiri
– volume: 14
  year: 2021
  ident: 41434_CR81
  publication-title: BioData Min.
  contributor:
    fullname: D Chicco
– volume: 16
  start-page: 829
  year: 2014
  ident: 41434_CR5
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/not330
  contributor:
    fullname: T Kaley
– volume: 473
  start-page: 194
  year: 2018
  ident: 41434_CR35
  publication-title: Mol. Cell. Endocrinol.
  doi: 10.1016/j.mce.2018.01.020
  contributor:
    fullname: P Kober
– volume: 22
  start-page: 278
  year: 2020
  ident: 41434_CR22
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noz160
  contributor:
    fullname: AI Islim
– volume: 19
  year: 2019
  ident: 41434_CR78
  publication-title: BMC Cancer
  contributor:
    fullname: Y Liu
– volume: 16
  start-page: e0252480
  year: 2021
  ident: 41434_CR61
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0252480
  contributor:
    fullname: KJ Suh
– volume: 21
  start-page: 901
  year: 2019
  ident: 41434_CR10
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noz061
  contributor:
    fullname: F Nassiri
– volume: 23
  start-page: 1231
  year: 2021
  ident: 41434_CR14
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noab106
  contributor:
    fullname: DN Louis
– volume: 2020
  start-page: 5042356
  year: 2020
  ident: 41434_CR43
  publication-title: Biomed. Res. Int.
  contributor:
    fullname: J Dong
– volume: 10
  year: 2020
  ident: 41434_CR46
  publication-title: Sci. Rep.
  contributor:
    fullname: Z Zador
– volume: 26
  start-page: 1572
  year: 2010
  ident: 41434_CR74
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btq170
  contributor:
    fullname: MD Wilkerson
– volume: 21
  start-page: i44
  year: 2019
  ident: 41434_CR2
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/noy143
  contributor:
    fullname: RY Huang
– volume: 14
  start-page: 4818
  year: 2022
  ident: 41434_CR66
  publication-title: Cancers
  doi: 10.3390/cancers14194818
  contributor:
    fullname: RD Neal
– volume: 20
  year: 2021
  ident: 41434_CR64
  publication-title: Mol. Cancer
  contributor:
    fullname: J Liu
– volume: 10
  start-page: 32
  year: 2019
  ident: 41434_CR25
  publication-title: Genes
  doi: 10.3390/genes10010032
  contributor:
    fullname: W Gai
– volume: 39
  start-page: 3839
  year: 2021
  ident: 41434_CR15
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.21.00784
  contributor:
    fullname: SLN Maas
– volume: 18
  year: 2017
  ident: 41434_CR55
  publication-title: Genome Biol.
  doi: 10.1186/s13059-017-1191-5
  contributor:
    fullname: S Kang
– volume: 13
  start-page: 2664
  year: 2021
  ident: 41434_CR3
  publication-title: Cancers
  doi: 10.3390/cancers13112664
  contributor:
    fullname: T Ius
SSID ssj0000391844
Score 2.5036585
Snippet Recurrence of meningiomas is unpredictable by current invasive methods based on surgically removed specimens. Identification of patients likely to recur using...
Abstract Recurrence of meningiomas is unpredictable by current invasive methods based on surgically removed specimens. Identification of patients likely to...
Abstract Recurrence of meningiomas is unpredictable by current invasive methods based on surgically removed specimens. Identification of patients likely to...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 5669
SubjectTerms Artificial Intelligence
Biopsy
Blood
Brain cancer
Central nervous system
DNA Methylation
Humans
Liquid Biopsy
Meningeal Neoplasms - diagnosis
Meningeal Neoplasms - genetics
Meningioma
Meningioma - diagnosis
Meningioma - genetics
Patients
Prognosis
Strategy
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9RAEC5kQfAirs_oKi14k7BJP9Ldx_WxLIKeXNhbk_QDA5JZzcxhFvzvVnVnhxkRvHhM0oRKV3VXVerrrwDehAH9jGpTPRgba9kmVRvbeMxapUcPq3nIhfbPX7qLS_npSl3ttfoiTFihBy4Tdxp0wwcrlewSNY_rhk6g00tt0Ckm38W8-7ZqL5nKe7CwmLrI5ZRMI8zpLPOegC4KJZJC1jcHnigT9v8tyvwTLLnnfc4fwP0lbGRnRdxjuBOnh3C3NJLcPoJfH-I6Y6omtkosFPgcDmX9FBhBsJZL6he9Lei3mvxXYITfyNyeMxsn9n38sRkDG8bV9bxldAqTyP9nRodQ2ELBOjP6d4uvyr2OCF70GC7PP359f1EvjRVqL61e10b5aLzC1EsSHZ23KWIYIgRFRzbq0BkMKghOwlPE8Is3yTc6esVjL6Tto3gCR9Nqis-AKS24Cn3i3lqpm9S3svWC90FaybmOFby9nWR3XfgzXK57C-OKShyqxGWVuJsK3pEediOJ-zrfQItwi0W4f1lEBSe3WnTLgpwdNx31eddKVvB69xiXEtVH-imuNmUMpp84DxU8LUrfSSK0phKyrsAcmMOBqIdPpvFbputuKas0jX7-Pz7uBdyjhveEWGnFCRytf27iSwyL1sOrvAJ-Az9iDEA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA_nHYIv4rfVUyL4JmXbfDTJk3h6xyJ4iHhwb6HNhxak3bt2H_bA_92ZtLu6Ij62Ce2QSTIzmV_mR8hr34CdkWXMG21CLsooc20KB1GrcGBhFfMp0f7pvFpeiI-X8vKALLd3YRBWud0T00bte4dn5AumKyTqVlIs6gZPAdy4eLu6ypE_CvOsM5nGLXLESoEJ26OT0_PPX3bnLVgJXQsx35spuF4MIu0SYLRARsFFfrNnm1IJ_3_5nX_DJ_-wR2f3yN3ZkaTvJs3fJwehe0BuT9SSm4fk54cwJpRVR_tI_QSog6607jxFUNb8iAzSmwkPl6NF8xQRHana50Dbjv5or9atp03br4YNxXuZSAcwULyWQueirAPF01z4VGI_QsDRI3Jxdvr1_TKfqRZyJ4wacy1d0E5CMCawQJ0zMYBjwjn6SyYoX2lwMxBgwmIAh4wV0RUqOMlCzYWpA39MDru-C08JlYoz6evInDFCFbEGdTjOai-MYEyFjLzZDrJdTRU1bMqEc20nlVhQiU0qsTcZOUE97HpiNez0or_-ZufFZb0qWGOEFFVEgsGqqTg4RrH0KoboKvjl8VaLdl6ig_09oTLyatcMiwszJnUX-vXUBwJSGIeMPJmUvpOEK4VJZZURvTcd9kTdb-na76mAd4lxpi7Us__L9ZzcQXJ7RKeU_Jgcjtfr8AJcoLF5Oc_uX-EFCSw
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBZpSqGX0vTpNCkq9Fbc2npY0qGUvkIopKcu5CZsPVpDsJP1LmQD-e-Zkb1Lt-yht921sIxmtPON59N8hLz1DcQZWca80Sbkoowy16ZwkLUKBxFWMZ8K7Wc_q9OZ-HEuz_fIWu5oWsBhZ2qHelKz-cX766vVJ9jwH8cj4_rDINJ2h-gDkwku8pt75D6DD-jxZxPcT__M3EBCg4VmVogyh9jNp3M0u2-zFatSS_9dOPRfOuVf8enkMXk0AUv6efSEA7IXuifkwSg1uXpKbr-FRWJddbSP1I8EOxhK685TJGlNX1FRejXy43KMcJ4iwyN1_xxo29GL9mrZetq0_eWwonhOE-UBBorHVOjUpHWg-HYXbpXUkJCA9IzMTr7_-nqaT9ILuRNGLXItXdBOQnImsGGdMzEAUOEc8ZMJylcaYAcSTlgMANBYEV2hgpMs1FyYOvDnZL_ru_CSUKk4k76OzBkjVBHrUpSOs9oLIxhTISPv1otsL8cOGzZVxrm2o0ksmMQmk9ibjHxBO2xGYnfs9EM__22nzWa9KlhjhBRVRMHBqqk4AKVYehVDdBVMebS2ol17nGW6QiV4JUVG3mwuw2bDCkrdhX45joEEFdYhIy9Go2-ehCuFRWaVEb3lDluPun2la_-kht4l5p26UIf_MfEr8hAV75GyUvIjsr-YL8Mx4KJF8zo5-x0_tAtQ
  priority: 102
  providerName: Scholars Portal
Title Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas
URI https://www.ncbi.nlm.nih.gov/pubmed/37704607
https://www.proquest.com/docview/2864389754/abstract/
https://www.proquest.com/docview/2864899334/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC10499807
https://doaj.org/article/d702b94546f74016b63743f1d7fefc6e
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdtx0Zfxr6XrQsa7G24sSXZkh7TrlkJpJRthbwZWx-doXWyOnlIYf_77mQ7NGNPe5GxLdvCd9L9TvrpjpBPtgQ7kyY-KpV2kUh8GikdG_BahQELK5kNC-2zi-z8Skzn6XyPZP1emEDaN2V1XN_cHtfVz8CtXN6aUc8TG13OThPE6SqWo32yLzl_4KOH8ZdrcFtEt0Mm5mrUiDAegHmC1gguovtD8oRLiYuCcscghbj9_wKbf3MmHxihyTPytEOPdNy28jnZc_UL8rjNJ7l5SX5_catArarpwlPbsuigKi1qS5GJ1Z1i2uhNS4KL0IxZijSOEOKzoVVNb6pf68rSslosmw3FzZiYA6ChuBeFdpFYG4pTuPCqkPIIWUavyNXk7MfpedTlV4iM0HIVqdQ4ZVLwwARGpTPaO0AjnCNI0k7aTAG2QFYJ8w5QGIu9iaUzKXMFF7pw_DU5qBe1e0toKjlLbeGZ0VrI2BeJSAxnhRVaMCbdgHzuf3K-bMNo5GH5m6u8lU4O0smDdPL7ATlBOWxrYgjscGFxd513ipBbGbNSi1RkHrMKZmXGAQ35xErvvMngk0e9FPOuXzY5Uxmme5epGJCP29vQo3CZpKjdYt3WAS8U_sOAvGmFvm1JrzQDonbUYaepu3dAiUPU7l5p3_3_o-_JIWa7R7pKwo_Iwepu7T4AJlqVQ-gIcwmlmnwdkkfj8fT7FI4nZxeX34ZhngHKmVDD0FX-AAgbFBs
link.rule.ids 230,315,733,786,790,870,891,2115,2236,12083,12792,21416,24346,27957,27958,31754,31755,33408,33409,33779,33780,43345,43635,43840,53827,53829,74102,74392,74659
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCMEF8SalgJG4oaiJ7cT2CfGqFmh7aqW9WYkfEAkl22b3sJX635lxvAuLEMfEVmJ5bM_r83yEvHEt6JmqDHmrtM9FGapc6cKC1yosaFjJXEy0n5zWs3PxdV7NU8BtTLDKzZkYD2o3WIyRHzJVI1G3rMS7xUWOrFGYXU0UGjfJLcG5QEifnMttjAWrnysh0l2ZgqvDUcSTARQVjEtwkV_t6KNYtv9ftubfkMk_dNDRfXIvGY_0_STtB-SG7x-S2xOd5PoRuf7klxFZ1dMhUDeB6KArbXpHEYiVHpE1ej1h4HLUYo4iiiNW-Bxp19Of3cWqc7TthsW4pngXEykARopXUWgqxDpSjODCpyLjEYKMHpPzo89nH2d5olfIrdBymavKemUrcMAEFqWzOngwRmAawUbSXrpagWmBoBIWPBhhrAi2kN5WzDdc6MbzJ2SvH3r_jNBKcla5JjCrtZBFaEpRWs4aJ7RgTPqMvN1MsllMVTRMzH5zZSaRGBCJiSIxVxn5gHLY9sQK2PHFcPndpA1lnCxYq0Ul6oCkgnVbczCGQulk8MHW8MuDjRRN2paj-b2IMvJ62wwbCrMkTe-H1dQHnFCYh4w8nYS-HQmXEhPJMiNqZznsDHW3pe9-xKLdJfqWqpD7_x_XK3JndnZybI6_nH57Tu4iuT2iU0p-QPaWlyv_AkygZfsyrvNfkh8G-Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgEYgL4k1gASNxQ1ETP2LnhIClWl4rDqzUm5X4sURCSXfTHroS_50Zxy0UIY6JrcTyjD0zns_zEfLStWBnZBnyVtc-F2WQua4LC1GrsGBhFXMx0f7lpDo-FR8XcpHwT2OCVW73xLhRu8HiGfmM6QqJupUUs5BgEV-P5q-X5zkySGGmNdFpXCXXwEoWyGagFmp33oKV0LUQ6d5MwfVsFHGXAKMFYxRc5Jd7timW8P-X3_k3fPIPezS_TW4lR5K-mSR_h1zx_V1yfaKW3NwjP4_8KqKsejoE6iZAHXSlTe8ogrLSIzJIbyY8XI4WzVFEdMRqnyPtevqjO193jrbdsBw3FO9lIh3ASPFaCk1FWUeKp7nwqch-hICj--R0_v7bu-M8US3kVtRqlWtpvbYSgjGBBepsHTw4Jpyjv1R75SoNbgYCTFjw4JCxIthCeSuZb7ioG88fkIN-6P0jQqXiTLomMFvXQhWhKUVpOWucqAVjymfk1XaSzXKqqGFiJpxrM4nEgEhMFIm5zMhblMOuJ1bDji-GizOTFpdxqmBtLaSoAhIMVm3FwTEKpVPBB1vBLw-3UjRpiY7mt0Jl5MWuGRYXZkya3g_rqQ8EpDAPGXk4CX03Eq4UJpVVRvSeOuwNdb-l777HAt4lxpm6UI__P67n5AaouPn84eTTE3ITee4RqFLyQ3Kwulj7p-ANrdpnUc1_AaYnCyU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Detection+of+diagnostic+and+prognostic+methylation-based+signatures+in+liquid+biopsy+specimens+from+patients+with+meningiomas&rft.jtitle=Nature+communications&rft.au=Herrgott%2C+Grayson+A&rft.au=Snyder%2C+James+M&rft.au=She%2C+Ruicong&rft.au=Malta%2C+Tathiane+M&rft.date=2023-09-13&rft.issn=2041-1723&rft.eissn=2041-1723&rft.volume=14&rft.issue=1&rft.spage=5669&rft_id=info:doi/10.1038%2Fs41467-023-41434-z&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon